References
-
1
Brandt L J, Kauvar D R.
Laser-induced transient regression of Barrett’s epithelium.
Gastrointest Endosc.
1992;
38
619-622
-
2
Berenson M M, Johnson T D, Markowitz N R. et al .
Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium.
Gastroenterology.
1993;
104
1686-1691
-
3
Garewal H, Ramsey L, Sharma P. et al .
Biomarker studies in reversed Barrett’s esophagus.
Am J Gastroenterol.
1999;
94
2829-2833
-
4
Ackroyd R, Brown N J, Davis M F. et al .
Photodynamic therapy for dysplastic Barrett’s oesophagus: a prospective, double blind, randomised, placebo controlled trial.
Gut.
2000;
47
612-617
-
5
Bergman J J, Fockens P.
Ablating Barrett’s metaplastic epithelium: are the techniques ready for clinical use?.
Gut.
2006;
55
1222-1223
-
6
Schoenfeld P, Scheiman J.
An evidence-based approach to studies of gastrointestinal therapies.
Clin Gastroenterol Hepatol.
2003;
1
57-63
-
7
Spechler S J.
Thermal ablation of Barrett’s esophagus: a heated debate.
Am J Gastroenterol.
2006;
101
1770-1772
-
8
Van Laethem J L, Peny M O. et al .
Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus.
Gut.
2000;
46
574-577
-
9
Shand A, Dallal H, Palmer K. et al .
Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation.
Gut.
2001;
48
580-581
-
10
Mino-Kenudson M, Ban S, Ohana M. et al .
Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy.
Am J Surg Pathol.
2007;
31
403-409
-
11
Krishnadath K K, Wang K K, Taniguchi K. et al .
Persistent genetic abnormalities in Barrett’s esophagus after photodynamic therapy.
Gastroenterology.
2000;
119
624-630
-
12
Hage M, Siersema P D, Vissers K J. et al .
Molecular evaluation of ablative therapy of Barrett’s oesophagus.
J Pathol.
2005;
205
57-64
-
13
Hage M, Siersema P D, Vissers K J. et al .
Genomic analysis of Barrett’s esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.
Int J Cancer.
2006;
118
155-160
-
14
Dvorak K, Ramsey L, Payne C M. et al .
Abnormal expression of biomarkers in incompletely ablated Barrett’s esophagus.
Ann Surg.
2006;
244
1031-1036
-
15
Pech O, Nagy C D, Gossner L. et al .
Photodynamic therapy of human Barrett’s cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Eur J Gastroenterol Hepatol.
2002;
14
657-662
-
16
Johnston C M, Schoenfeld L P, Mysore J V. et al .
Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus.
Gastrointest Endosc.
1999;
50
86-92
-
17
Pasricha P J, Hill S, Wadwa K S. et al .
Endoscopic cryotherapy: experimental results and first clinical use.
Gastrointest Endosc.
1999;
49
627-631
-
18
Johnston M H.
Cryotherapy and other newer techniques.
Gastrointest Endosc Clin N Am.
2003;
13
491-504
-
19
Prasad G A, Wang K K, Buttar N S. et al .
Long term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus.
Gastroenterology.
2007;
132
1226-1233
-
20
Das A, Singh V, Fleischer D E. et al .
A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data.
Am J Gastroenterol.
2008;
103
1340-1345
-
21
Kelty C J, Ackroyd R, Brown N J. et al .
Endoscopic ablation of Barrett’s oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
Aliment Pharmacol Ther.
2004;
20
1289-1296
-
22
Dulai G S, Jensen D M, Cortina G. et al .
Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus.
Gastrointest Endosc.
2005;
61
232-240
-
23
Sharma P, Wani S, Weston A P. et al .
A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.
Gut.
2006;
55
1233-1239
-
24
Overholt B F, Lightdale C J, Wang K K. et al .
Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial.
Gastrointest Endosc.
2005;
62
488-498
-
25
Shaheen N J, Sharma P, Overholt B F. et al .
A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett’s esophagus containing dysplasia: interim results of the AIM dysplasia trial.
Gastroenterology.
2008;
134
A37
-
26
Overholt B F, Wang K K, Burdick J S. et al .
Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia.
Gastrointest Endosc.
2007;
66
460-468
-
27
Ganz R A, Utley D S, Stern R A. et al .
Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus.
Gastrointest Endosc.
2004;
60
1002-1010
-
28
Dunkin B J, Martinez J, Bejarano P A. et al .
Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device.
Surg Endosc.
2006;
20
125-130
-
29
Sharma V K, Wang K K, Overholt B F. et al .
Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients.
Gastrointest Endosc.
2007;
65
185-195
-
30
Fleischer D E, Overholt B F, Sharma V K. et al .
Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up.
Gastrointest Endosc.
2008;
Jun 16 [Epub ahead of print]
-
31
Ell C, May A, Pech O. et al .
Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer).
Gastrointest Endosc.
2007;
65
3-10
-
32
Wang K K, Sampliner R E.
Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus.
Am J Gastroenterol.
2008;
103
788-797
-
33
Gondrie J J, Pouw R E, Sondermeijer C M. et al .
Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system.
Endoscopy.
2008;
40
370-379
-
34
Gondrie J J, Pouw R E, Sondermeijer C M. et al .
Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.
Endoscopy.
2008;
40
359-369
-
35
Johnston M H, Eastone J A, Horwhat J D. et al .
Cryoablation of Barrett’s esophagus: a pilot study.
Gastrointest Endosc.
2005;
62
842-848
-
36
Dumot J A, Vargo J J, Zuccaro G. et al .
Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (IMCA) in high risk non-surgical patients.
Gastrointest Endosc.
2008;
67
AB176
-
37
Seewald S, Akaraviputh T, Seitz U. et al .
Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma.
Gastrointest Endosc.
2003;
57
854-859
-
38
Giovannini M, Bories E, Pesenti C. et al .
Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
Endoscopy.
2004;
36
782-787
-
39
Peters F P, Kara M A, Rosmolen W D. et al .
Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study.
Am J Gastroenterol.
2006;
101
1449-1457
-
40
Larghi A, Lightdale C J, Ross A S. et al .
Long term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Endoscopy.
2007;
39
1086-1091
-
41
Yoshinaga S, Gotoda T, Kusano C. et al .
Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction.
Gastrointest Endosc.
2008;
67
202-209
-
42
Spechler S J, Sharma P, Traxler B. et al .
Gastric and esophageal pH in patients with Barrett’s esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial.
Am J Gastroenterol.
2006;
101
1964-1971
-
43
Sampliner R E, Camargo L, Fass R.
Impact of esophageal acid exposure on the endoscopic reversal of Barrett’s esophagus.
Am J Gastroenterol.
2002;
97
270-272
-
44
Kovacs B J, Chen Y K, Lewis T D. et al .
Successful reversal of Barrett’s esophagus with multipolar electrocoagulation despite inadequate acid suppression.
Gastrointest Endosc.
1999;
49
547-553
-
45
Hornick J L, Mino-Kenudson M, Lauwers G Y. et al .
Buried Barrett’s epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities.
Am J Gastroenterol.
2008;
103
38-47
-
46
Ackroyd R, Brown N J, Stephenson T J. et al .
Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed?.
J Clin Pathol.
1999;
52
509-512
-
47
Leedham S J, Preston S L, McDonald S A. et al .
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus.
Gut.
2008;
57
1041-1048
-
48
Weston A P, Sharma P, Banerjee S. et al .
Visible endoscopic and histologic changes in the cardia, before and after complete Barrett’s esophagus ablation.
Gastrointest Endosc.
2005;
61
515-521
-
49
Sampliner R E, Camargo E, Prasad A R.
Association of ablation of Barrett’s esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia.
Dis Esophagus.
2006;
19
277-279
-
50
Fass R, Garewal H S, Hayden C W. et al .
Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett’s esophagus.
Gastrointest Endosc.
2001;
53
711-716
-
51
Fennerty M B, Corless C L, Sheppard B. et al .
Pathological documentation of complete elimination of Barrett’s metaplasia following endoscopic multipolar electrocoagulation therapy.
Gut.
2001;
49
142-144
-
52
Prasad G A, Wang K K, Halling K C. et al .
Utility of biomarkers in prediction of response to ablative therapy in Barrett’s esophagus.
Gastroenterology.
2008;
135
370-379
G. W. FalkMD MS
Department of Gastroenterology and Hepatology
Desk A-31
Cleveland Clinic
9500 Euclid Avenue, Cleveland
Ohio 44195, USA
Fax: 01-216-4446302
Email: falkg@ccf.org
